Is there an association between parathyroid disorders (e.g., primary hyperparathyroidism) and stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Association Between Parathyroid Disorders and Stroke

Yes, there is a significant association between parathyroid disorders, particularly primary hyperparathyroidism (PHPT), and increased stroke risk, though the relationship appears to be mediated primarily through cardiovascular risk factors rather than representing a direct causal pathway.

Evidence for the Association

The most recent and comprehensive evidence comes from a 2026 systematic review and meta-analysis demonstrating that hyperparathyroidism is associated with increased stroke risk 1. This analysis found:

  • Patients with elevated PTH levels had a 49% increased odds of stroke (OR: 1.49,95% CI: 1.38-1.61)
  • Prospective studies showed a 38% increased hazard of stroke (HR: 1.38,95% CI: 1.09-1.75)
  • Stroke patients had significantly higher PTH levels (mean difference: 10.30 pg/mL higher than controls)

Mechanisms and Clinical Context

Cardiovascular Manifestations in PHPT

Current French expert consensus guidelines 2, 3 classify cardiovascular manifestations as "non-classical" signs of PHPT that are not known to be reversible after parathyroid surgery. This is a critical distinction from classical manifestations (bone, kidney, muscle) which do show reversibility.

Hypertension is the primary cardiovascular link, with PHPT patients showing a 30% increased risk of hypertension 2. The proposed mechanisms include:

  • Elevated PTH impairing vascular endothelial vasodilation
  • Increased aldosterone/renin ratio
  • Hypercalcemia-related increased endothelial response to catecholamines

Vascular Changes

A 2026 meta-analysis 4 demonstrates that PHPT patients exhibit:

  • Significantly increased carotid intima-media thickness (IMT) compared to controls
  • Markedly reduced flow-mediated dilation (FMD), indicating endothelial dysfunction
  • These represent early structural arterial changes rather than advanced atherosclerotic plaque formation

Important Caveats

The evidence does not establish a conclusive causal relationship 1. The association appears mediated through:

  1. Hypertension as the primary pathway - observational studies suggested hypertension reversibility after parathyroidectomy, but randomized controlled trials have not confirmed this 2
  2. Endothelial dysfunction - representing an early, potentially reversible stage of vascular disease 4
  3. Age and gender interactions - the association is stronger in elderly women, possibly related to compensatory hyperparathyroidism from osteoporosis 5

Clinical Implications

Current Guideline Recommendations

Cardiovascular involvement is NOT currently an indication for parathyroid surgery 3. The French consensus explicitly states:

  • Grade A++ recommendation: Cardiovascular morbidity and mortality are increased in PHPT patients
  • However, parathyroidectomy's effect on reducing cardiovascular risk remains uncertain
  • Surgery indications remain focused on classical target organ damage (bone, kidney) and biochemical severity

Risk Stratification Approach

When evaluating a patient with parathyroid disorders for stroke risk:

  1. Assess traditional cardiovascular risk factors aggressively, particularly:

    • Blood pressure control (30% increased hypertension risk)
    • Age and gender (higher risk in elderly women)
    • Duration of disease (longer exposure increases risk)

  2. Consider vascular assessment in select cases:

    • Carotid ultrasound for IMT measurement may help risk stratification
    • Flow-mediated dilation testing if available
    • These are not routine but may inform management in borderline surgical candidates

  3. Do not use stroke risk alone as an indication for parathyroidectomy - the evidence for reversibility is insufficient

Special Populations

In chronic kidney disease patients with secondary hyperparathyroidism, the relationship is complex and potentially bidirectional 6. Paradoxically, lower PTH levels (≤150 pg/mL) were associated with increased stroke risk in peritoneal dialysis patients, while vitamin D supplementation appeared protective.

Bottom Line

The association between parathyroid disorders and stroke is real and clinically significant, but represents an indirect relationship mediated through hypertension and endothelial dysfunction rather than a direct effect. Manage these patients with aggressive cardiovascular risk factor modification, but do not perform parathyroidectomy solely for stroke prevention 3. Surgical decisions should be based on established criteria: symptomatic disease, target organ damage (bone/kidney), or biochemical severity as defined in current guidelines.

References

1
Research

Association between Hyperparathyroidism and the Risk of Cerebrovascular Disease in the General Population.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2026

2
Guideline

chapter 2: primary hyperparathyroidism: diagnosis.

Annales d'endocrinologie, 2025

Related Questions

Can primary hyperparathyroidism cause elevated LDL cholesterol in a patient with chronic pancreatitis‑related malabsorption who has no coronary or carotid atherosclerotic plaque?
Is routine screening for polymyalgia rheumatica recommended in asymptomatic adults, particularly those over 65 years old?
Are patients who have undergone esophagectomy prone to malnutrition after surgery, especially when they have chronic reduction in gastric acid (hydrochloric acid)?
In a pregnant woman at 14 weeks gestation with a 1‑hour glucose tolerance test value of 191 mg/dL who was started on oral metformin, is the routine 1‑hour screening glucose test at 28 weeks still required?
What is the appropriate administration route and dosing schedule for treating a patient with pulmonary hypertension?
Should vaginal estrogen and other hormone therapy be held until after completing isotretinoin (Accutane)?
What are the MRI characteristics of a uterine adenomyoma?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.